Blockade of the endocannabinoid system for the reduction of cardiometabolic risk factors.
Samaha
Frederick F
FF
Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Chou
Carol M
CM
D000818:Animals; D063385:Cannabinoid Receptor Modulators / Q000037:antagonists & inhibitors* / Q000502:physiology; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000378:metabolism / Q000517:prevention & control*; D004195:Disease Models, Animal; D063388:Endocannabinoids; D004734:Energy Metabolism / Q000502:physiology; D006801:Humans; D051379:Mice; D009765:Obesity / Q000150:complications* / Q000378:metabolism; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use; D011720:Pyrazoles / Q000009:adverse effects / Q000627:therapeutic use; D051381:Rats; D000077285:Rimonabant; D012307:Risk Factors
D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant